Zhang, Hong <br/><br/>
Identification of new biomarkers for clinical trials of Hsp90 inhibitors.  [electronic resource] 

 -  Molecular cancer therapeutics  May 2006 
 - 1256-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1535-7163 
<br/><br/><label>Standard No.: </label>10.1158/1535-7163.MCT-05-0537  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Benzoquinones<br/>Biomarkers, Tumor--chemistry<br/>Breast Neoplasms--drug therapy<br/>Clinical Trials, Phase I as Topic<br/>Dose-Response Relationship, Drug<br/>Down-Regulation<br/>Female<br/>HSP90 Heat-Shock Proteins--antagonists & inhibitors<br/>In Vitro Techniques<br/>Insulin-Like Growth Factor Binding Protein 2--blood<br/>Lactams, Macrocyclic<br/>Mice<br/>Mice, Nude<br/>Protein Structure, Tertiary--drug effects<br/>Receptor, ErbB-2--blood<br/>Rifabutin--analogs & derivatives<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays